​

COMPASS Pathways (CMPS) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

CMPS Stock Forecast

COMPASS Pathways (CMPS) stock forecast, based on 10 Wall Street analysts, predicts a 12-month average price target of $23.00, with a high of $23.00 and a low of $23.00. This represents a 634.82% increase from the last price of $3.13.

- $5 $10 $15 $20 $25 High: $23 Avg: $23 Low: $23 Last Closed Price: $3.13

CMPS Stock Rating

COMPASS Pathways stock's rating consensus is Buy, based on 10 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 10 0 10 Strong Sell Sell Hold Buy Strong Buy

CMPS Price Target Upside V Benchmarks

TypeNameUpside
StockCOMPASS Pathways634.82%
SectorHealthcare Stocks 35.25%
IndustryMedical Care Facilities Stocks23.83%
IdeaPsychedelic Stocks List324.26%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$23.00
Last Closing Price$3.13$3.13$3.13
Upside/Downside--634.82%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2537---10
Mar, 2537---10
Feb, 2546---10
Jan, 2546---10
Dec, 2446---10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 22, 2024Leonid TimashevRBC Capital$23.00$7.43209.56%634.82%
Jun 05, 2024Vikram PurohitMorgan Stanley$23.00$6.70243.28%634.82%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 04, 2025H.C. WainwrightBuyBuyhold
Nov 11, 2024Canaccord GenuityBuyBuyhold
Nov 04, 2024H.C. WainwrightBuyBuyhold
Nov 01, 2024RBC CapitalOutperformOutperformhold
Jul 22, 2024RBC CapitalOutperforminitialise
Jun 05, 2024Morgan StanleyOverweightOverweighthold
Apr 01, 2024Morgan StanleyOverweightinitialise
Oct 13, 2022OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.32$-2.30----
Avg Forecast$-2.15$-2.37$-2.07$-1.76$-1.44$-0.96
High Forecast$-1.92$-2.24$-1.69$-1.76$-1.44$-0.96
Low Forecast$-2.38$-2.69$-2.66$-1.76$-1.44$-0.96
Surprise %7.91%-2.95%----

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast---$560.00K$10.47M$169.80M
High Forecast---$560.00K$10.47M$169.80M
Low Forecast---$560.00K$10.47M$169.80M
Surprise %------

Net Income Forecast

$-200M $-160M $-120M $-80M $-40M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-118.46M$-155.12M----
Avg Forecast$-109.85M$-120.75M$-105.74M$-89.55M$-73.48M$-48.78M
High Forecast$-98.13M$-114.53M$-86.01M$-89.55M$-73.48M$-48.78M
Low Forecast$-121.57M$-137.33M$-135.59M$-89.55M$-73.48M$-48.78M
Surprise %7.84%28.46%----

CMPS Forecast FAQ

Is COMPASS Pathways stock a buy?

COMPASS Pathways stock has a consensus rating of Buy, based on 10 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that COMPASS Pathways is a favorable investment for most analysts.

What is COMPASS Pathways's price target?

COMPASS Pathways's price target, set by 10 Wall Street analysts, averages $23 over the next 12 months. The price target range spans from $23 at the low end to $23 at the high end, suggesting a potential 634.82% change from the previous closing price of $3.13.

How does COMPASS Pathways stock forecast compare to its benchmarks?

COMPASS Pathways's stock forecast shows a 634.82% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the medical care facilities stocks industry (23.83%), leading the psychedelic stocks list (324.26%) investment idea.

What is the breakdown of analyst ratings for COMPASS Pathways over the past three months?

  • April 2025: 30.00% Strong Buy, 70.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 30.00% Strong Buy, 70.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is COMPASS Pathways’s EPS forecast?

COMPASS Pathways's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.07, marking a -10.00% decrease from the reported $-2.3 in 2024. Estimates for the following years are $-1.76 in 2026, $-1.44 in 2027, and $-0.96 in 2028.

What is COMPASS Pathways’s revenue forecast?

COMPASS Pathways's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $560K, followed by $10.47M for 2027, and $169.8M for 2028.

What is COMPASS Pathways’s net income forecast?

COMPASS Pathways's net income forecast for the fiscal year ending in December 2025 stands at $-106M, representing a -31.83% decrease from the reported $-155M in 2024. Projections indicate $-89.554M in 2026, $-73.48M in 2027, and $-48.783M in 2028.